Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Financial Services
Sydney-based JBF Solutions operates in Financial Services. Privately held, at jbfsolutions.com.au. It holds two addresses on record, all in Australia. It employs 1 person, on the record. It lists system implementation, process improvement and strategy development among its specialties. One Australian registration (ABN) is a confirmed match. It is listed alongside two similar brands, mostly in Pharmaceutical Manufacturing.
ABN11684577919
| JBF SOLUTIONS PTY LTD | ABN 11684577919 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
JBF Solutions adopts a client-first approach and empowers its clients with practical solutions to achieve their goals.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Queensland entity on the ABR: JBF SOLUTIONS PTY LTD (ABN 11 684 577 919), high confidence.
1 counted staff profiles at January 2026, inside the self-reported 1 band.
Two addresses on record, Australia only. Primary: Sydney.
None linked to this brand.
Nine tags on the brand's own list, among them system implementation, process improvement and strategy development.
Two peer profiles on record: Accelera Biopharma and TIO International.